Laser use for cutaneous vascular alterations of cosmetic interest

Dermatologic Therapy

Volumn 25, Issue 4, 2012, Pages 340-351

  Bencini, Pier Luca ^a   Tourlaki, Athanasia ^a,b   De Giorgi, Vincenzo ^c   Galimberti, Michela ^a  

^a C/o ICLID ^*  (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

hemangiomas; intense pulsed light; Nd:YAG laser; port wine stains; pulsed dye laser; skin vascular lesions; telangiectasias

Indexed keywords

ANGIOMA; ARTICLE; BLOOD VESSEL DIAMETER; CAPILLARY HEMANGIOMA; CLINICAL PRACTICE; CONGENITAL BLOOD VESSEL MALFORMATION; COOLING; EPIDERMIS; ESTHETIC SURGERY; HEMANGIOMA; HEMODYNAMICS; HUMAN; LASER; LASER SURGERY; LEG VARICOSIS; NEODYMIUM LASER; NEVUS FLAMMEUS; PATIENT SELECTION; POIKILODERMA; PULSED DYE LASER; ROSACEA; SPIDER VEIN; TELANGIECTASIA; TREATMENT CONTRAINDICATION; VASCULAR SURGERY;

HEMANGIOMA; HUMANS; INTENSE PULSED LIGHT THERAPY; LASER THERAPY; LASERS, DYE; LASERS, SOLID-STATE; SKIN DISEASES, VASCULAR; SKIN NEOPLASMS; TELANGIECTASIS; VASCULAR MALFORMATIONS; VENOUS INSUFFICIENCY;

EID: 84865969514     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2012.01463.x     Document Type: Article

References (80)

1. Solomon H, Goldman L, Henderson B, Richfield D, Franzen M,. Histopathology of the laser treatment of port-wine lesions. Biopsy studies of treated areas observed up to three years after laser impacts. J Invest Dermatol 1968: 50: 141-146.
2. Anderson RR, Parrish JA,. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983: 220: 524-527. (Pubitemid 13114117)
3. Tanzi EL, Lupton JR, Alster TS,. Lasers in dermatology: four decades of progress. J Am Acad Dermatol 2003: 49: 1-31. (Pubitemid 36801627)
4. Groot D, Rao J, Johnston P, Nakatsui T,. Algorithm for using a long-pulsed Nd:YAG laser in the treatment of deep cutaneous vascular lesions. Dermatol Surg 2003: 29: 35-42. (Pubitemid 36114727)
5. Adamic M, Troilius A, Adatto M, Drosner M, Dahmane R,. Vascular lasers and IPLS: guidelines for care from the European Society for Laser Dermatology. J Cosmet Laser Ther 2007: 9: 113-124. (Pubitemid 46897787)
6. Rothfleisch JE, Kosmann MK, Levine VJ, Ashinoff R,. Laser treatment of congenital and acquired vascular lesions: update on lasers: a review. Dermatol Clin 2002: 20: 1-18. (Pubitemid 34126310)
7. Jasim ZF, Woo WK, Handley JM,. Long-pulsed (6-ms) pulsed dye laser treatment of rosacea-associated telangiectasia using subpurpuric clinical threshold. Dermatol Surg 2004: 30: 37-40. (Pubitemid 38174026)
8. Landthaler M, Hohenleutner U, Abd El Raheem TA,. Therapy of vascular lesions in the head and neck area by means of argon, Nd: YAG, and flashlamp-pumped pulsed dye lasers. Adv Otorhinolaryngol 1995: 49: 81-86.
9. Anderson RR, Parrish JA,. The optics of human skin. J Invest Dermatol 1981: 77: 13-19. (Pubitemid 12229295)
10. Landthaler M, Haina D, Brunner R, Waidelich W, Braun-Falco O,. Neodymium-YAG laser therapy for vascular lesions. J Am Acad Dermatol 1986: 14: 107-117. (Pubitemid 16137935)
11. Anderson RR,. Optics of the skin. In:, Lim HW, Soter NA, eds. Clinical photomedicine. New York, NY: Marcel Dekker, 1993: 19-35.
12. Ross EV, Smirnov M, Pankratov M, Altshuler G,. Intense pulsed light and laser treatment of facial telangiectasias and dyspigmentation: some theoretical and practical comparisons. Dermatol Surg 2005: 31: 1188-1198. (Pubitemid 41587069)
13. Jacobs AH, Walton RG,. The incidence of birthmarks in the neonate. Pediatrics 1976: 58: 218-222.
14. Barsky SH, Rosen S, Geer DE, Noe JM,. The nature and evolution of port wine stains: a computer-assisted study. J Invest Dermatol 1980: 74: 154-157. (Pubitemid 10184146)
15. Geronimus R, Ashinoff R,. The medical necessity of evaluation and treatment of port wine stains. J Dermatol Surg Oncol 1991: 17: 76-79.
16. Alster TS, Lewis AB,. Dermatologic laser surgery. A review. Dermatol Surg 1996: 22: 797-805.
17. Bucci J, Goldberg D,. Past, present and future: vascular laser/light devices. J Cosmet Laser Ther 2006: 8: 149-153.
18. Motley RJ, Lanigan SW, Katugampola GA,. Videomicroscopy predicts outcome in treatment of port-wine stains. Arch Dermatol 1997: 133: 921-922. (Pubitemid 27337564)
19. Lanigan SW,. Port wine stains on the lower limb: response to pulsed dye laser therapy. Clin Exp Dermatol 1996: 21: 88-92. (Pubitemid 26227937)
20. Renfro L, Geronemus RG,. Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser. Arch Dermatol 1993: 129: 182-188. (Pubitemid 23063870)
21. Eubanks LE, McBurney EI,. Videomicroscopy of port-wine stains: correlation of location and depth of lesion. J Am Acad Dermatol 2001: 44: 948-951. (Pubitemid 32493444)
22. Yohn JJ, Huff JC, Aeling JL, Walsh P, Morelli JG,. Lesion size is a factor for determining the rate of port-wine stain clearing following pulsed dye laser treatment in adults. Cutis 1997: 59: 267-270. (Pubitemid 127471501)
23. Jasim ZF, Handley JM,. Treatment of pulsed dye laser-resistant port-wine stain birthmarks. J Am Acad Dermatol 2007: 57: 677-682. (Pubitemid 47384910)
24. Kono T, Sakurai H, Takeuchi M, et al. Treatment of resistant port-wine stains with a variable-pulsed dye laser. Dermatol Surg 2007: 33: 951-956. (Pubitemid 47106736)
25. Bernstein EF,. High-energy 595 nm pulsed dye laser improves refractory port wine-stains. Dermatol Surg 2006: 32: 26-33.
26. Hsia J, Lowery JA, Zelicson B,. Treatment of leg teleangectasia using a long-pulse dye laser at 595 nm. Laser Surg Med 1997: 20: 1-5. (Pubitemid 27121388)
27. West TB, Alster TS,. Comparison of the long-pulse dye (490-595 nm) and KTP (532 nm) lasers in the treatment of facial and leg teleangectasias. Dermatol Surg 1998: 24: 221-226. (Pubitemid 28134558)
28. Reichert D,. Evaluation of the long-pulse dye laser for the treatment of leg teleangectasia. Dermatol Surg 1998: 24: 737-740. (Pubitemid 28348083)
29. Waldorf HA, Alster TS, McMillan K, Kauvar AN, Geronemus RG, Nelson JS,. Effect of dynamic cooling on 585 nm pulsed dye laser treatment of port-wine stain birthmarks. Dermatol Surg 1997: 23: 657-662. (Pubitemid 27329828)
30. Kauvar A,. Long pulse and high energy pulsed dye laser treatment of port wine stains and hemangioma. Presented at the 24th Annual Meeting of the American Society of Dermatological Surgery, Boston, May 1997.
31. Sivarajan V, Maclaren WM, Mackay IR,. The effect of varying pulse duration, wavelength, spot size and fluence on the response of previously treated capillary vascular malformations to pulsed-dye laser treatment. Ann Plast Surg 2006: 57: 25-32. (Pubitemid 43982248)
32. Bencini PL,. The multilayer technique: a new and fast approach for flash-pumped pulsed (FLPP) dye laser treatment of port wine stains (Preliminary reports). Dermatol Surg 1999: 25: 786-789. (Pubitemid 29480972)
33. Lorenz S, Brunnberg S, Landthaler M, Hoenleutner U,. Regarding the multilayer technique for treatment of PWS. Dermatol Surg 2001: 27: 90. (Pubitemid 32107631)
34. Rajaratnam R, Laughlin SA, Dudley D,. Pulsed dye laser double-pass treatment of patients with resistant capillary malformations. Lasers Med Sci 2011: 26: 487-492.
35. Ho WS, Ying SY, Chan PC, Chann HH,. Treatment of port wine stain with intense pulsed light: a prospective study. Dermatol Surg 2004: 30: 887-890.
36. Klein A, Bäumler W, Landthaler M, Babilas P,. Laser and IPL treatment of port-wine stains: therapy options, limitations, and practical aspects. Lasers Med Sci 2011: 26: 845-859.
37. Izikson L, Nelson JS, Anderson RR,. Treatment of hypertrophic and resistant port wine stains with a 755 nm laser: a case series of 20 patients. Lasers Surg Med 2009: 41: 427-432.
38. Yang MU, Yaroslavsky AN, Farinelli WA, et al. Long-pulsed neodymium: yttrium-aluminium-garnet laser treatment for port-wine stains. J Am Acad Dermatol 2005: 52: 480-490.
39. Finn MC, Glowacki J, Mulliken JB,. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983: 18: 894-900. (Pubitemid 14175292)
40. Alster TS,., Tanzi EL,. Combined 595-nm and 1064-nm laser irradiation of recalcitrant and hypertrophic port-wine stains in children and adults. Dermatol Surg 2009: 35: 914-918.
41. Borges da Costa J, Boixeda P, Moreno C, Santiago J,. Treatment of resistant port-wine stains with a pulsed dual wavelength 595 and 1064 nm laser: a histochemical evaluation of the vessel wall destruction and selectivity. Photomed Laser Surg 2009: 27: 599-605.
42. Whang KK, Byun JY, Kim SH,. A dual-wavelength approach with 585-nm pulsed-dye laser and 800-nm diode laser for treatment-resistant port-wine stains. Clin Exp Dermatol 2009: 34: 436-437.
43. Zhao Y, Zhou Z, Zhou G, et al. Efficacy and safety of hemoporfin in photodynamic therapy for port-wine stain: a multicenter and open-labeled phase IIa study. Photodermatol Photoimmunol Photomed 2011: 27: 17-23.
44. Baker ER, Manders E, Whitney CW,. Growth of cavernous hemangioma with puberty. Clin Pediatr (Phila) 1985: 24: 596-598. (Pubitemid 15024951)
45. Mulliken JB,. Treatment of hemangiomas. In:, Mulliken JB, Young AE, eds. Vascular birthmarks: hemangiomas and malformations, vol. 77. Philadelphia, PA: WB Saunders, 1988: 193-199.
46. Frieden IJ, Eichenfield LF, Esterly NB, Geronemus R, Mallory SB,. Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol 1997: 37: 631-637.
47. Leonardi-Bee J, Batta K, O'Brien C, Bath-Hextall FJ,. Interventions for infantile haemangiomas (strawberry birthmarks) of the skin. Cochrane Database Syst Rev 2011: 11: CD006545.
48. Sommers Smith SK, Smith DM,. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim 2002: 38: 298-304. (Pubitemid 35204978)
49. Schlosser KA,. Infantile hemangioma: how to treat this benign neoplasm of childhood. JAAPA 2009: 22: 46-49.
50. Goldman MP,. Laser treatment of cutaneous vascular lesions. In:, Goldman MP, ed. Cutaneous and cosmetic laser surgery. London: Mosby Elsevier, 2006: 31-91.
51. Hunzeker CM, Geronemus RG,. Treatment of superficial infantile hemangiomas of the eyelid using the 595-nm pulsed dye laser. Dermatol Surg 2010: 36: 590-597.
52. Rizzo C, Brightman L, Chapas AM, et al. Outcomes of childhood hemangiomas treated with the pulsed-dye laser with dynamic cooling: a retrospective chart analysis. Dermatol Surg 2009: 35: 1947-1954.
53. Bruckner AL, Frieden IJ,. Hemangiomas of infancy. J Am Acad Dermatol 2003: 48: 477-493. (Pubitemid 36397008)
54. Srinivas CR, Kumaresan M,. Lasers for vascular lesions: standard guidelines of care. Indian J Dermatol Venereol Leprol 2011: 77: 349-368.
55. Saafan AM, Salah MM,. Using pulsed dual-wavelength 595 and 1064 nm is more effective in the management of hemangiomas. J Drugs Dermatol 2010: 9: 310-314.
56. Li DN, Gold MH, Sun ZS, Tang AR, Wang HB, Sheng-Kang L,. Treatment of infantile hemangioma with optimal pulse technology. J Cosmet Laser Ther 2010: 12: 145-150.
57. Alcántara González J, Boixeda P, Truchuelo Díez M, Lõpez Gutiérrez J, Olasolo P,. Ablative fractional yttrium-scandium-gallium-garnet laser for scarring residual haemangiomas and scars secondary to their surgical treatment. J Eur Acad Dermatol Venereol 2012: 26: 477-482.
58. Laubach HJ, Anderson RR, Luger T, Manstein D,. Fractional photothermolysis for involuted infantile hemangioma. Arch Dermatol 2009: 145: 748-750.
59. Alam M, Dover JS, Arndt KA,. Treatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura threshold. Dermatol Surg 2003: 29: 681-685. (Pubitemid 36870138)
60. Clementoni MT, Gilardino P, Muti GF, et al. Facial teleangectasias: our experience in treatment with IPL. Lasers Surg Med 2005: 37: 9-13. (Pubitemid 41105873)
61. Nymann P, Hedelund L, Haedersdal M,. Long-pulsed dye laser versus intense pulsed light for the treatment of facial telangiectasias: a randomized controlled trial. J Eur Acad Dermatol Venereol 2010: 24: 143-146.
62. Jørgensen GF, Hedelund L, Haedersdal M,. Long-pulsed dye laser versus intense pulsed light for photodamaged skin: a randomized split-face trial with blinded response evaluation. Lasers Surg Med 2008: 40: 293-299. (Pubitemid 351920378)
63. Bevin AA, Parlette EC, Domankevitz Y, Ross EV,. Variable-pulse Nd: YAG laser in the treatment of facial telangiectasias. Dermatol Surg 2006: 32: 7-12.
64. Bernstein EF, Kligman A,. Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser. Lasers Surg Med 2008: 40: 233-239. (Pubitemid 351628524)
65. Clark SM, Lanigan SW, Marks R,. Laser treatment of erythema and telangiectasia associated with rosacea. Lasers Med Sci 2002: 17: 26-33. (Pubitemid 34145977)
66. Menezes N, Moreira A, Mota G, Baptista A,. Quality of life and rosacea: pulsed dye laser impact. J Cosmet Laser Ther 2009: 11: 139-141.
67. Schroeter CA, Haaf-von Below S, Neuman HA,. Effective treatment of rosacea using intense pulsed light systems. Dermatol Surg 2005: 31: 1285-1289. (Pubitemid 41587036)
68. Neuhaus IM, Zane LT, Tope WD,. Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea. Dermatol Surg 2009: 35: 920-928.
69. Meijs MM, Blok FA, de, Rie MA,. Treatment of poikiloderma of Civatte with the pulsed dye laser: a series of patients with severe depigmentation. J Eur Acad Dermatol Venereol 2006: 20: 1248-1251. (Pubitemid 44614623)
70. Tierney EP, Hanke CW,. Treatment of poikiloderma of Civatte with ablative fractional laser resurfacing: prospective study and review of the literature. J Drugs Dermatol 2009: 8: 527-534.
71. Behroozan DS, Goldberg LH, Glaich AS, Dai T, Friedman PM,. Fractional photothermolysis for treatment of poikiloderma of Civatte. Dermatol Surg 2006: 32: 298-301.
72. Browse NL, Irvine AT, Wilson NM,. Embryology and radiographic anatomy. In:, Browse NL, Irvine AT, Wilson NM, eds. Disease of veins, 2nd ed. London: Arnold, 1999: 23-48.
73. Gloviczki P, Duncan A, Kalra M, et al. Vascular malformations: an update. Perspect Vasc Surg Endovasc Ther 2009: 21: 133-148.
74. Araki CT, Back TL, Padberg FT, et al. The significance of calf muscle pump function in venous ulceration. J Vasc Surg 1994: 20: 872-877.
75. Eklof B, Rutherford RB, Bergan JJ, et al. Revision of CEAP classification of chronic venous disorders: consensus statement. J Vasc Surg 2004: 40: 1248-1252. (Pubitemid 40037299)
76. Gloviczki P,. The care of patients with varicose veins and associated chronic venous disease: clinical practice guidelines of the Society for Vascular Surgery and The American Venous Forum. J Vasc Surg 2011: 53: 2s-48s.
77. Bjordal RI,. Circulation patterns in incompetent perforating vein on the calf and in saphenous system in primary varicose veins. Acta Chir Scand 1972: 138: 251-261.
78. Akesson H, Brudin L, Cwifield W, Ohlin P, Plate G,. Does the correction of superficial insufficiency and perforating veins improve venous function in patients with deep venous insufficiency? Phlebology 1990: 5: 113-123. (Pubitemid 20272841)
79. Gonzales-Zeh R, Armisen R, Barahona S,. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up. J Vasc Surg 2008: 48: 940-946.
80. Omura NE, Dover JS, Arndt KA, Kuavar AN,. Treatment of reticular leg veins with a 1064 nm long pulsed Nd: YAG laser. J Am Acad Dermatol 2003: 48: 76-81. (Pubitemid 36091537)